Disclosure Of First-Time Adoption [Text Block]

Captor Therapeutics S.A. - Filing #6226332

Concept	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01	As at 2020-01-01
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	—	39 882 297 PLN	2 968 461 PLN	—	—	141 143 534 PLN	—	141 143 534 PLN	98 153 259 PLN	—	0 PLN	139 516 PLN	—	—	89 434 346 PLN	53 518 617 PLN	—	0 PLN	49 830 702 PLN	0 PLN	147 092 666 PLN	136 000 PLN	136 000 PLN	143 404 751 PLN	—	4 003 703 PLN	4 003 703 PLN	89 434 346 PLN	0 PLN	—	—	147 092 666 PLN	143 404 751 PLN	—	—	0 PLN	0 PLN	0 PLN	—	3 687 916 PLN	3 687 916 PLN	3 687 916 PLN	136 700 PLN	79 129 831 PLN	79 129 831 PLN	0 PLN	0 PLN	0 PLN	0 PLN	0 PLN	14 444 015 PLN	0 PLN	0 PLN	4 003 500 PLN	0 PLN	136 700 PLN	4 003 500 PLN	14 444 015 PLN	79 129 831 PLN	89 433 646 PLN	0 PLN	89 433 646 PLN	79 129 831 PLN
Comprehensive income	0 PLN	—	—	13 507 PLN	13 622 812 PLN	—	0 PLN	—	—	0 PLN	—	—	13 622 812 PLN	13 636 319 PLN	—	—	67 962 835 PLN	—	—	—	—	—	—	—	67 962 632 PLN	—	—	—	—	203 PLN	0 PLN	—	—	0 PLN	0 PLN	—	—	—	67 962 835 PLN	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit (loss)	0 PLN	—	—	0 PLN	13 636 319 PLN	—	0 PLN	—	—	0 PLN	—	—	13 636 319 PLN	13 636 319 PLN	—	—	67 962 632 PLN	—	—	—	—	—	—	—	67 962 632 PLN	—	—	—	—	0 PLN	0 PLN	—	—	0 PLN	0 PLN	—	—	—	67 962 632 PLN	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—